BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 25979820)

  • 1. Proteomics and autoimmune kidney disease.
    Rovin BH; Klein JB
    Clin Immunol; 2015 Nov; 161(1):23-30. PubMed ID: 25979820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of urinary proteomics for the detection of biomarkers of kidney diseases.
    Jiang S; Wang Y; Liu Z
    Adv Exp Med Biol; 2015; 845():151-65. PubMed ID: 25355578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomic approaches in kidney disease biomarker discovery.
    Fenton RA
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1817-F1821. PubMed ID: 30230371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using isolated rat kidney to discover kidney origin biomarkers in urine.
    Jia L
    Adv Exp Med Biol; 2015; 845():175-85. PubMed ID: 25355580
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics approaches in the quest of kidney disease biomarkers.
    Frantzi M; Bitsika V; Charonis A; Vlahou A
    Prilozi; 2011; 32(2):33-51. PubMed ID: 22286613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biomarker discovery for kidney diseases by mass spectrometry.
    Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary proteomics for the study of genetic kidney diseases.
    Raimondo F; Cerra D; Magni F; Pitto M
    Expert Rev Proteomics; 2016; 13(3):309-24. PubMed ID: 26698090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teaching molecular genetics: Chapter 3--Proteomics in nephrology.
    Groenen PJ; van den Heuvel LP
    Pediatr Nephrol; 2006 May; 21(5):611-8. PubMed ID: 16572342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.
    Wu J; Chen YD; Gu W
    J Zhejiang Univ Sci B; 2010 Apr; 11(4):227-37. PubMed ID: 20349519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Urinary proteomics and metabolomics in the diagnosis of pediatric disorders.
    Vaidyanathan K
    Proteomics Clin Appl; 2015 Jun; 9(5-6):482-9. PubMed ID: 25631340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic analysis reveals differentially secreted proteins in the urine from patients with clear cell renal cell carcinoma.
    Sandim V; Pereira Dde A; Kalume DE; Oliveira-Carvalho AL; Ornellas AA; Soares MR; Alves G; Zingali RB
    Urol Oncol; 2016 Jan; 34(1):5.e11-25. PubMed ID: 26420021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urine 2DE proteome analysis in healthy condition and kidney disease.
    Martin-Lorenzo M; Gonzalez-Calero L; Zubiri I; Diaz-Payno PJ; Sanz-Maroto A; Posada-Ayala M; Ortiz A; Vivanco F; Alvarez-Llamas G
    Electrophoresis; 2014 Sep; 35(18):2634-41. PubMed ID: 24913465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urine as a source for clinical proteome analysis: from discovery to clinical application.
    Rodríguez-Suárez E; Siwy J; Zürbig P; Mischak H
    Biochim Biophys Acta; 2014 May; 1844(5):884-98. PubMed ID: 23831154
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteomic analysis of urinary exosomes in cardiovascular and associated kidney diseases by two-dimensional electrophoresis and LC-MS/MS.
    Zubiri I; Vivanco F; Alvarez-Llamas G
    Methods Mol Biol; 2013; 1000():209-20. PubMed ID: 23585095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in urinary proteome analysis and biomarker discovery.
    Fliser D; Novak J; Thongboonkerd V; Argilés A; Jankowski V; Girolami MA; Jankowski J; Mischak H
    J Am Soc Nephrol; 2007 Apr; 18(4):1057-71. PubMed ID: 17329573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applications of urinary proteomics in renal disease research using animal models.
    Lv Y; Cai G; Chen X
    Adv Exp Med Biol; 2015; 845():145-50. PubMed ID: 25355577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capillary zone electrophoresis on-line coupled to mass spectrometry: A perspective application for clinical proteomics.
    Pejchinovski M; Hrnjez D; Ramirez-Torres A; Bitsika V; Mermelekas G; Vlahou A; Zürbig P; Mischak H; Metzger J; Koeck T
    Proteomics Clin Appl; 2015 Jun; 9(5-6):453-68. PubMed ID: 25641766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine sample preparation in 96-well filter plates to characterize inflammatory and infectious diseases of the urinary tract.
    Yu Y; Pieper R
    Adv Exp Med Biol; 2015; 845():77-87. PubMed ID: 25355571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteomics as a tool for clinically relevant biomarker discovery and validation.
    Duncan MW; Hunsucker SW
    Exp Biol Med (Maywood); 2005 Dec; 230(11):808-17. PubMed ID: 16339745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.